Research at Liver Institute

 

Patient statistics and Consents

liver institute PLLC provide patients with the best, most current recommendations and treatments. If a patients consent to be part of our clinical trials, we analyze their data and monitor the progress of their liver disease in correlation to their daily functioning and other measures of wellbeing.

Picture1.png

 

Projects in Progress

1.     Title: Fungal and Bacterial Infections in Patients with Acute Decompensated Cirrhosis; a Retrospective Review

IRB: University of Arizona

Principal Investigators: Shahid Habib.

Affiliations: Liver Institute PLLC.

Funding: Liver Institute PLLC

Status: Results analyzed

Presentations:

A.   Factors predictive of infections in acute decompensated cirrhosis patients may help identify infections sooner than later: value of SIRS criteria upon admission.

Shahid Habib, Nehali Patel, Courtney Walker, Sarah Patel, Sandeep Yarlagadda, Chiu-Hsieh Hsu and Thomas D Boyer

AASLD. Hepatology October 2016. 64 sup1: Page 1023A, Abstract 2056

B.    Vancomycin in acutely decompensated cirrhotic caused higher mortality and     antimicrobial treatment overall failed to improve survival.
Authors: Sandeep Yarlagadda, Nehali Patel, Courtney Walker, Sarah Patel, Chiu-Hsieh Hsu and Shahid Habib.

DDW April 2017

 

2.     Project Title: Liver Disease Registry. Research to Practice: A Quality Assured Practice Project

IRB: Western Institutional Review Board

Principal Investigators: Shahid Habib.

Affiliations: Liver Institute PLLC.

Funding: Liver Institute PLLC

Status: Data collection

 

3.     Project Title: Screening for Insulin Resistance in Liver Disease Patients in liver disease sub-specialty clinic: A retrospective review of prospectively collected data

IRB:             Western Institutional Review Board

University of Arizona

Principal Investigators: Shahid Habib.

Affiliations: Liver Institute PLLC.

Funding: Liver Institute PLLC

Status: Data collection

 

4.     Project Title: Improving awareness of available anti-HCV treatment modalities among nephrologists and anti HCV treatment in patients with chronic kidney disease and end stage renal disease: Application of guidelines in clinical practice

IRB:             Western Institutional Review Board, in process

Principal Investigators: Shahid Habib.

Affiliations: Liver Institute PLLC.

Funding: AbbVie Pharmaceutical

Status: Protocol review; awaiting final decision

Projects completed and manuscripts in progress

1.     Title: False positive findings indicating emergent abdominal surgery in patients with cirrhosis Authors: Bashar Ahmed1, Abbas Rana2, Cassandra Murzle1, Bobby Kalb3 and Shahid Habib1

Affiliations: 1Liver Research Institute, University of Arizona. Department of surgery, division of transplantation, Loma Linda University. Department of Medicine.

Status: Manuscript submitted and under peer review.

 

2.     Prevention of Coccidioidomycosis Infection Among Liver Transplant Recipients: A Single Center Experience.

Investigators: 1Tirdad Zangeneh, MD. 2Shahid Habib, MD.

Affiliations: 1Division of Infectious Disease University of Arizona. and 2Liver Institute PLLC,

Status: Manuscript submitted, peer review process 

 

3.     Title: Does the Alcoholic Liver Disease/ Non-alcoholic fatty liver disease Index (ANI) predict mortality in Alcoholic Hepatitis?

Authors: Shahid Habib, Sandeep Yarlagadda, Traci Murakami, Chris Dominguez, Varun Takyar, Patel, Ahmad Safdar, and Thomas D Boyer.

Affiliations: 1Liver Institute PLLC, 2Department of Medicine, University of Arizona.,

Status: Manuscript preparation